Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma

EBioMedicine

Volumn 8, Issue , 2016, Pages 195-202

  Chng, Kern Rei ^a   Chan, Sock Hoai ^b   Ng, Amanda Hui Qi ^a   Li, Chenhao ^a   Jusakul, Apinya ^b   Bertrand, Denis ^a   Wilm, Andreas ^a   Choo, Su Pin ^b   Tan, Damien Meng Yew ^c   Lim, Kiat Hon ^c   Soetinko, Roy ^c   Ong, Choon Kiat ^b   Duda, Dan G ^e   Dima, Simona ^f   Popescu, Irinel ^f   Wongkham, Chaisiri ^g   Feng, Zhu ^h   Yeoh, Khay Guan ^h,i   Teh, Bin Tean ^b,d   Yongvanit, Puangrat ^g   Wongkham, Sopit ^g   Bhudhisawasdi, Vajaraphongsa ^g   Khuntikeo, Narong ^g   Tan, Patrick ^a,d   Pairojkul, Chawalit ^g   Ngeow, Joanne ^b,d   Nagarajan, Niranjan ^a   more..

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f FUNDENI CLINICAL INSTITUTE   (Romania)

^g KHON KAEN UNIVERSITY   (Thailand)

^h Dept Medicine Endocrinol Diabet   (Singapore)

ⁱ NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Cancer; Cholangiocarcinoma; Liver fluke; Microbiome

Indexed keywords

RNA 16S;

ARTICLE; BACTERIAL METABOLISM; BIFIDOBACTERIACEAE; BILE DUCT CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; DIETZIACEAE; DISEASE ASSOCIATION; DNA LIBRARY; ENTEROBACTERIACEAE; GASTRIC MUCOSA; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MAJOR CLINICAL STUDY; OPISTHORCHIS VIVERRINI; OXALOBACTERACEAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONADACEAE; STENOTROPHOMONAS; TAXONOMIC IDENTIFICATION; TUMOR MICROENVIRONMENT; ADULT; AGED; ANIMAL; ANTIBODY SPECIFICITY; BILE DUCT NEOPLASMS; BIODIVERSITY; CELL TRANSFORMATION; CHOLANGIOCARCINOMA; COMPLICATION; FEMALE; MALE; METAGENOME; METAGENOMICS; MICROFLORA; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PROCEDURES;

ADULT; AGED; ANIMALS; BILE DUCT NEOPLASMS; BIODIVERSITY; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METAGENOME; METAGENOMICS; MICROBIOTA; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; ORGAN SPECIFICITY; RNA, RIBOSOMAL, 16S;

EID: 84971637001     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.04.034     Document Type: Article

References (59)

1. Aagaard K., Ma J., Antony K.M., Ganu R., Petrosino J., Versalovic J. The placenta harbors a unique microbiome. Sci. Transl. Med. 2014, 6:237-265.
2. Abubucker S., Segata N., Goll J., Schubert A.M., Izard J., Cantarel B.L., Rodriguez-Mueller B., Zucker J., Thiagarajan M., Henrissat B., et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 2012, 8.
3. Aviles-Jimenez F., Guitron A., Segura-Lopez F., Mendez-Tenorio A., Iwai S., Hernandez-Guerrero A., Torres J. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clin. Microbiol. Infect. 2016, 22(178):e111-e122.
4. Begley M., Gahan C.G., Hill C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 2005, 29:625-651.
5. Bongers G., Pacer M.E., Geraldino T.H., Chen L., He Z., Hashimoto D., Furtado G.C., Ochando J., Kelley K.A., Clemente J.C., et al. Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J. Exp. Med. 2014, 211:457-472.
6. Boonyanugomol W., Chomvarin C., Sripa B., Bhudhisawasdi V., Khuntikeo N., Hahnvajanawong C., Chamsuwan A. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB 2012, 14:177-184.
7. Bragazzi M.C., Cardinale V., Carpino G., Venere R., Semeraro R., Gentile R., Gaudio E., Alvaro D. Cholangiocarcinoma: epidemiology and risk factors. Transl. Gastrointest. Cancer 2012, 1:21-32.
8. Brook I. Aerobic and anaerobic microbiology of biliary tract disease. J. Clin. Microbiol. 1989, 27:2373-2375.
9. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., Fierer N., Pena A.G., Goodrich J.K., Gordon J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336.
10. Carpenter H.A. Bacterial and parasitic cholangitis. Mayo Clin. Proc. 1998, 73:473-478.
11. Chan-On W., Nairismagi M.L., Ong C.K., Lim W.K., Dima S., Pairojkul C., Lim K.H., McPherson J.R., Cutcutache I., Heng H.L., et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat. Genet. 2013, 45:1474-1478.
12. Debruyne P.R., Bruyneel E.A., Li X., Zimber A., Gespach C., Mareel M.M. The role of bile acids in carcinogenesis. Mutat. Res. 2001, 480-481:359-369.
13. Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., Lakshmanan A., Wade W.G. The human oral microbiome. J. Bacteriol. 2010, 192:5002-5017.
14. Elomari M., Coroler L., Verhille S., Izard D., Leclerc H. Pseudomonas monteilii sp. nov., isolated from clinical specimens. Int. J. Syst. Bacteriol. 1997, 47:846-852.
15. Fava G. Molecular mechanisms of cholangiocarcinoma. World J. Gastrointest. Pathophysiol. 2010, 1:12-22.
16. Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013, 7:880-884.
17. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
18. Jusakul A., Khuntikeo N., Haigh W.G., Kuver R., Ioannou G.N., Loilome W., Namwat N., Bhudhisawasdi V., Pugkhem A., Pairojkul C., et al. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Asian Pac. J. Cancer Prev. 2012, 13(Suppl):77-82.
19. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
20. Koerner R.J., Goodfellow M., Jones A.L. The genus Dietzia: a new home for some known and emerging opportunist pathogens. FEMS Immunol. Med. Microbiol. 2009, 55:296-305.
21. Kostic A.D., Chun E., Robertson L., Glickman J.N., Gallini C.A., Michaud M., Clancy T.E., Chung D.C., Lochhead P., Hold G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013, 14:207-215.
22. Kostic A.D., Gevers D., Pedamallu C.S., Michaud M., Duke F., Earl A.M., Ojesina A.I., Jung J., Bass A.J., Tabernero J., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22:292-298.
23. Kostic A.D., Gevers D., Siljander H., Vatanen T., Hyotylainen T., Hamalainen A.M., Peet A., Tillmann V., Poho P., Mattila I., et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 2015, 17:260-273.
24. Langille M.G., Zaneveld J., Caporaso J.G., McDonald D., Knights D., Reyes J.A., Clemente J.C., Burkepile D.E., Vega Thurber R.L., Knight R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013, 31:814-821.
25. Lazaridis K.N., Gores G.J. Cholangiocarcinoma. Gastroenterology 2005, 128:1655-1667.
26. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
27. Lluch J., Servant F., Paisse S., Valle C., Valiere S., Kuchly C., Vilchez G., Donnadieu C., Courtney M., Burcelin R., et al. The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One 2015, 10.
28. Louis P., Hold G.L., Flint H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12:661-672.
29. Lozupone C., Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 2005, 71:8228-8235.
30. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 1999, 65:4506-4512.
31. McDonald D., Price M.N., Goodrich J., Nawrocki E.P., DeSantis T.Z., Probst A., Andersen G.L., Knight R., Hugenholtz P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012, 6:610-618.
32. Miller C.S., Baker B.J., Thomas B.C., Singer S.W., Banfield J.F. EMIRGE: reconstruction of full-length ribosomal genes from microbial community short read sequencing data. Genome Biol. 2011, 12:R44.
33. Nagarajan N., Bertrand D., Hillmer A.M., Zang Z.J., Yao F., Jacques P.E., Teo A.S., Cutcutache I., Zhang Z., Lee W.H., et al. Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol. 2012, 13:R115.
34. Olsson R., Bjornsson E., Backman L., Friman S., Hockerstedt K., Kaijser B., Olausson M. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J. Hepatol. 1998, 28:426-432.
35. Ong S.H., Kukkillaya V.U., Wilm A., Lay C., Ho E.X., Low L., Hibberd M.L., Nagarajan N. Species identification and profiling of complex microbial communities using shotgun Illumina sequencing of 16S rRNA amplicon sequences. PLoS One 2013, 8.
36. Ong C.K., Subimerb C., Pairojkul C., Wongkham S., Cutcutache I., Yu W., McPherson J.R., Allen G.E., Ng C.C., Wong B.H., et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet. 2012, 44:690-693.
37. Patel R.K., Jain M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS One 2012, 7.
38. Perez P.N., Ramirez M.A., Fernandez J.A., de Guevara L.L. A patient presenting with cholangitis due to Stenotrophomonas maltophilia and Pseudomonas aeruginosa successfully treated with intrabiliary colistine. Curr. Infect. Dis. Rep. 2014, 6:5147.
39. Plieskatt J.L., Deenonpoe R., Mulvenna J.P., Krause L., Sripa B., Bethony J.M., Brindley P.J. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J. 2013, 27:4572-4584.
40. Price L.B., Liu C.M., Johnson K.E., Aziz M., Lau M.K., Bowers J., Ravel J., Keim P.S., Serwadda D., Wawer M.J., et al. The effects of circumcision on the penis microbiome. PLoS One 2010, 5.
41. Pruesse E., Quast C., Knittel K., Fuchs B.M., Ludwig W., Peplies J., Glockner F.O. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007, 35:7188-7196.
42. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
43. Rathinavelu S., Zavros Y., Merchant J.L. Acinetobacter lwoffii infection and gastritis. Microbes Infect. 2003, 5:651-657.
44. Roscetto E., Vitiello L., Muoio R., Soriano A.A., Iula V.D., Vollaro A., De Gregorio E., Catania M.R. In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells. Front. Microbiol. 2015, 6:723.
45. Schwabe R.F., Jobin C. The microbiome and cancer. Nat. Rev. Cancer 2013, 13:800-812.
46. Segata N., Waldron L., Ballarini A., Narasimhan V., Jousson O., Huttenhower C. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 2012, 9:811-814.
47. Sia D., Hoshida Y., Villanueva A., Roayaie S., Ferrer J., Tabak B., Peix J., Sole M., Tovar V., Alsinet C., et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013, 144:829-840.
48. Sivan A., Corrales L., Hubert N., Williams J.B., Aquino-Michaels K., Earley Z.M., Benyamin F.W., Lei Y.M., Jabri B., Alegre M.L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015, 350:1084-1089.
49. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J.P., Letulle S., Langella P., Corthier G., Tran Van Nhieu J., Furet J.P. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011, 6.
50. Sutter V.L. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl. Microbiol. 1968, 16:1532-1538.
51. Swartz M.A., Iida N., Roberts E.W., Sangaletti S., Wong M.H., Yull F.E., Coussens L.M., DeClerck Y.A. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res. 2012, 72:2473-2480.
52. Tsujii M., Kawano S., Tsuji S., Nagano K., Ito T., Hayashi N., Fusamoto H., Kamada T., Tamura K. Ammonia: a possible promotor in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett. 1992, 65:15-18.
53. Tyson G.L., El-Serag H.B. Risk factors for cholangiocarcinoma. Hepatology 2011, 54:173-184.
54. Wu T., Zhang Z., Liu B., Hou D., Liang Y., Zhang J., Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics 2013, 14:669.
55. Yarza P., Yilmaz P., Pruesse E., Glockner F.O., Ludwig W., Schleifer K.H., Whitman W.B., Euzeby J., Amann R., Rossello-Mora R. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat. Rev. Microbiol. 2014, 12:635-645.
56. Yoshimoto S., Loo T.M., Atarashi K., Kanda H., Sato S., Oyadomari S., Iwakura Y., Oshima K., Morita H., Hattori M., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499:97-101.
57. Young N.D., Nagarajan N., Lin S.J., Korhonen P.K., Jex A.R., Hall R.S., Safavi-Hemami H., Kaewkong W., Bertrand D., Gao S., et al. The Opisthorchis viverrini genome provides insights into life in the bile duct. Nat. Commun. 2014, 5:4378.
58. Yue J.C., Clayton M.K. A similarity measure based on species proportions. Commun. Stat. Theory Methods 2005, 34:2123-2131.
59. Zhang W.C., Shyh-Chang N., Yang H., Rai A., Umashankar S., Ma S., Soh B.S., Sun L.L., Tai B.C., Nga M.E., et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 2012, 148:259-272.